DE69635459D1 - Acetylcholinesteraseinhibitoren zur behandlung und diagnose von atemstörungen während des schlafes - Google Patents

Acetylcholinesteraseinhibitoren zur behandlung und diagnose von atemstörungen während des schlafes

Info

Publication number
DE69635459D1
DE69635459D1 DE69635459T DE69635459T DE69635459D1 DE 69635459 D1 DE69635459 D1 DE 69635459D1 DE 69635459 T DE69635459 T DE 69635459T DE 69635459 T DE69635459 T DE 69635459T DE 69635459 D1 DE69635459 D1 DE 69635459D1
Authority
DE
Germany
Prior art keywords
pct
breathtures
diagnosis
treatment
acetylcholinesterase inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69635459T
Other languages
English (en)
Other versions
DE69635459T2 (de
Inventor
Jan Hedner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMAPNEA AB, HELSINGBORG, SE
Original Assignee
CURAPATH GOETEBORG AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CURAPATH GOETEBORG AB filed Critical CURAPATH GOETEBORG AB
Publication of DE69635459D1 publication Critical patent/DE69635459D1/de
Application granted granted Critical
Publication of DE69635459T2 publication Critical patent/DE69635459T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Radiation-Therapy Devices (AREA)
DE69635459T 1995-12-19 1996-12-17 Acetylcholinesteraseinhibitoren zur behandlung und diagnose von atemstörungen während des schlafes Expired - Lifetime DE69635459T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9504537A SE9504537D0 (sv) 1995-12-19 1995-12-19 Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
SE9504537 1995-12-19
PCT/SE1996/001677 WO1997022339A1 (en) 1995-12-19 1996-12-17 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method

Publications (2)

Publication Number Publication Date
DE69635459D1 true DE69635459D1 (de) 2005-12-22
DE69635459T2 DE69635459T2 (de) 2006-08-03

Family

ID=20400641

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635459T Expired - Lifetime DE69635459T2 (de) 1995-12-19 1996-12-17 Acetylcholinesteraseinhibitoren zur behandlung und diagnose von atemstörungen während des schlafes

Country Status (11)

Country Link
US (1) US6034117A (de)
EP (1) EP0923370B1 (de)
JP (1) JP3756193B2 (de)
AT (1) ATE309795T1 (de)
AU (1) AU701911B2 (de)
CA (1) CA2240717C (de)
DE (1) DE69635459T2 (de)
DK (1) DK0923370T3 (de)
ES (1) ES2256865T3 (de)
SE (1) SE9504537D0 (de)
WO (1) WO1997022339A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135825A0 (en) 1997-11-14 2001-05-20 Akzo Nobel Nv Use of mirtazapine for treating sleep apneas
US6352715B1 (en) * 1998-02-19 2002-03-05 Sagittarius Life Science Corp Transdermal rate-controlled delivery of Huperzine A for treatment of alzheimer's disease
US6262081B1 (en) * 1998-07-10 2001-07-17 Dupont Pharmaceuticals Company Composition for and method of treating neurological disorders
DE19856897A1 (de) * 1998-12-10 2000-06-15 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum zur Unterdrückung von Schnarchgeräuschen
KR100437105B1 (ko) * 1998-12-24 2004-06-23 얀센 파마슈티카 엔.브이. 방출 조절형 갈란타민 조성물
DE10004790B4 (de) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
US20070173893A1 (en) * 2000-10-20 2007-07-26 Pitts Walter C Method and apparatus for preventing obstructive sleep apnea
FR2820423B1 (fr) * 2001-02-05 2005-12-02 Assist Publ Hopitaux De Paris Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations
CN1194688C (zh) * 2001-07-03 2005-03-30 山东绿叶制药股份有限公司 石杉碱甲及其衍生物或其盐的注射用缓释微球及其制备方法
US20030225031A1 (en) * 2002-05-21 2003-12-04 Quay Steven C. Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid
AU2003287433A1 (en) * 2002-11-01 2004-06-07 Oregon Health And Science University Treatment of hyperkinetic movement disorder with donepezil
US20040266659A1 (en) * 2003-06-27 2004-12-30 Stephen LaBerge Substances that enhance recall and lucidity during dreaming
WO2005016327A2 (en) * 2003-08-13 2005-02-24 Janssen Pharmaceutica, N.V. Treatment of sleep disorders with cholinesterase inhibitors
US7795307B2 (en) 2003-10-21 2010-09-14 Colucid Pharmaceuticals, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
US7984714B2 (en) 2006-09-29 2011-07-26 Nellcor Puritan Bennett Llc Managing obstructive sleep apnea and/or snoring using local time released agents
CA2677241A1 (en) 2007-02-02 2008-08-14 Colucid Pharmaceuticals, Inc. Compounds that inhibit cholinesterase
JP2010533717A (ja) * 2007-07-18 2010-10-28 コルシド・ファーマシューティカルズ・インコーポレイテッド 覚醒を促進する方法
EP2251010A1 (de) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Verwendungen von Thiabendazol und Derivaten davon zur Behandlung neurologischer Leiden
CN103458899A (zh) * 2011-01-28 2013-12-18 辉达斯医学研究所 治疗阻塞性睡眠呼吸暂停的方法
US9642841B1 (en) 2014-03-14 2017-05-09 James M. Hand Snoring treatment
JP6526475B2 (ja) * 2015-04-30 2019-06-05 サンスター株式会社 経皮唾液腺投与用の唾液分泌促進剤
CA3016110C (en) 2016-05-11 2020-09-01 Jan Hedner Sultiame for the treatment of sleep apnea

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278679A (en) * 1980-05-01 1981-07-14 Chromalloy American Corporation Combination of two or more drugs in a single dosage form wherein one of the drugs is a physostigmine compound
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
DE4115558A1 (de) * 1991-05-13 1992-11-19 Dresden Arzneimittel Prophylaktisches antidot gegen phosphororganische gifte
US5312817A (en) * 1991-05-14 1994-05-17 Ernir Snorrason Treatment of fatigue syndrome
DE19548812A1 (de) * 1995-12-27 1997-07-03 Hoechst Ag Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation

Also Published As

Publication number Publication date
AU1217697A (en) 1997-07-14
WO1997022339A1 (en) 1997-06-26
CA2240717A1 (en) 1997-06-26
ATE309795T1 (de) 2005-12-15
ES2256865T3 (es) 2006-07-16
AU701911B2 (en) 1999-02-11
US6034117A (en) 2000-03-07
SE9504537D0 (sv) 1995-12-19
CA2240717C (en) 2002-11-26
EP0923370B1 (de) 2005-11-16
JP3756193B2 (ja) 2006-03-15
DK0923370T3 (da) 2006-03-27
EP0923370A2 (de) 1999-06-23
DE69635459T2 (de) 2006-08-03
JP2000511873A (ja) 2000-09-12

Similar Documents

Publication Publication Date Title
DE69635459D1 (de) Acetylcholinesteraseinhibitoren zur behandlung und diagnose von atemstörungen während des schlafes
DE69616376D1 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DE69317578D1 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
DE69507029T2 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
DE69329559T2 (de) Verwendung von mannosephosphaten zur behandlung von fibrotischen störungen
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE59401401D1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
ATE217197T1 (de) Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
DE69725879D1 (de) VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN
DE69636393D1 (de) Montirelin zur verhinderung der schlafapnoe
DE69634487D1 (de) Verfahren zur behandlung navikularer krankheiten bei pferden
DE69525631T2 (de) Verwendung von prostaglandinen zur herstellung eines arzneimittels zur prävention und behandlung des sekundären katarakts
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
DE60118363D1 (de) Methoden zur behandlung des kryptorchysmus
DE69832796D1 (de) Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: PHARMAPNEA AB, HELSINGBORG, SE

8364 No opposition during term of opposition